FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

63083007: Cyclobenzaprine hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
104859018 Cyclobenzaprine hydrochloride en Synonym Active Entire term case insensitive SNOMED CT core module
802327014 Cyclobenzaprine hydrochloride (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cyclobenzaprine hydrochloride Is a Product containing cyclobenzaprine false Inferred relationship Existential restriction modifier
Cyclobenzaprine hydrochloride Is a Cyclobenzaprine false Inferred relationship Existential restriction modifier
Cyclobenzaprine hydrochloride Is a Drug allergen false Inferred relationship Existential restriction modifier
Cyclobenzaprine hydrochloride Is modification of Cyclobenzaprine true Inferred relationship Existential restriction modifier
Cyclobenzaprine hydrochloride Is a Centrally acting muscle relaxant true Inferred relationship Existential restriction modifier
Cyclobenzaprine hydrochloride Is a Skeletal muscle relaxant true Inferred relationship Existential restriction modifier
Cyclobenzaprine hydrochloride Is a Organic cyclic compound true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Cyclobenzaprine hydrochloride Has active ingredient False Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) Has active ingredient False Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) Has active ingredient False Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely cyclobenzaprine hydrochloride 5 milligram/1 each conventional release oral tablet Has active ingredient False Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely cyclobenzaprine hydrochloride 10 milligram/1 each conventional release oral tablet Has active ingredient False Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely cyclobenzaprine hydrochloride 7.5 milligram/1 each conventional release oral tablet Has active ingredient False Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely cyclobenzaprine hydrochloride 10 milligram/1 each conventional release oral tablet Has active ingredient False Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine hydrochloride 10 milligram/1 each conventional release oral tablet Has basis of strength substance True Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine hydrochloride 5 milligram/1 each conventional release oral tablet Has active ingredient False Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine hydrochloride 5 milligram/1 each conventional release oral tablet Has basis of strength substance True Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine hydrochloride 7.5 milligram/1 each conventional release oral tablet Has active ingredient False Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine hydrochloride 7.5 milligram/1 each conventional release oral tablet Has basis of strength substance True Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine hydrochloride 5 milligram/1 each conventional release oral tablet Has precise active ingredient True Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine hydrochloride 7.5 milligram/1 each conventional release oral tablet Has precise active ingredient True Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine hydrochloride 10 milligram/1 each conventional release oral tablet Has precise active ingredient True Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) Has precise active ingredient False Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) Has precise active ingredient False Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine hydrochloride 15 milligram/1 each prolonged-release oral capsule (clinical drug) Has precise active ingredient True Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine hydrochloride 15 milligram/1 each prolonged-release oral capsule (clinical drug) Has basis of strength substance True Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine hydrochloride 30 milligram/1 each prolonged-release oral capsule (clinical drug) Has precise active ingredient True Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine hydrochloride 30 milligram/1 each prolonged-release oral capsule (clinical drug) Has basis of strength substance True Cyclobenzaprine hydrochloride Inferred relationship Existential restriction modifier 1

This concept is not in any reference sets

Back to Start